Karoly Nikolich

Fondateur chez Circuit Therapeutics, Inc.

Profil

Karoly Nikolich founded AGY Therapeutics, Inc. in 1998, where he worked as Chief Executive & Scientific Officer, Director from 1998 to 2005 and Circuit Therapeutics, Inc. in 2010, where he is working as President from 2010.
Dr. Nikolich also founded MapLight Therapeutics, Inc. and Hummingbird Diagnostics GmbH, where he worked as Director.
Dr. Nikolich also currently works at Alkahest, Inc., as Chairman & Chief Executive Officer from 2014, Excelimmune, Inc., as Director, NeuroTherapia, Inc., as Director from 2020, Chase Therapeutics Corp., as Director, Schaller-Nikolich Stiftung gGmbH, as Managing Director, Engrail Therapeutics, Inc., as Director, Selonterra, Inc., as Independent Director, Pivotal Bioventure Partners Investment Advisor LLC, as Venture Partner from 2017, and Nan Fung Life Sciences, as Advisor.
Dr. Nikolich also formerly worked at Amnestix, Inc., as Chief Executive Officer from 2007 to 2008, Neurofluidics, Inc., as Director & Chief Executive Officer from 2007 to 2013, Angiochem, Inc., as Chairman from 2005 to 2015, Nevis Brands, Inc., as Chairman from 2015 to 2021, Neuropore Therapies, Inc., as Chairman, Chase Pharmaceuticals Corp., as Director, Neuroscience Institute of Schizophrenia & Allied Disorders, as Executive Director, Stanford University School of Medicine, as Executive Director from 2005 to 2007, Genentech, Inc., as Head-Neuroscience Program from 1983 to 1995, Lynx Therapeutics, Inc., as Vice President-Research from 1997 to 1998, Biovail Corp., as Advisor from 2009 to 2010, Stanford University, as Professor, biOasis Technologies, Inc., as Board Member from 2013 to 2015, Axaron Bioscience AG, as Member-Supervisory Board from 1996 to 1998, and dievini Verwaltungs GmbH, as Advisor from 2007 to 2009.
Dr. Nikolich received his doctorate degree from Tulane University (Louisiana) and undergraduate degree from Eotvos Lorand University.

Postes actifs de Karoly Nikolich

Sociétés	Poste	Début
Circuit Therapeutics, Inc.	Fondateur	01/10/2010
Excelimmune, Inc.	Directeur/Membre du Conseil	-
Alkahest, Inc.	Directeur Général	01/07/2014
Chase Therapeutics Corp.	Directeur/Membre du Conseil	-
Pivotal Bioventure Partners Investment Advisor LLC	Private Equity Investor	01/01/2017
Engrail Therapeutics, Inc.	Directeur/Membre du Conseil	-
NeuroTherapia, Inc.	Directeur/Membre du Conseil	22/09/2020
Schaller-Nikolich Stiftung gGmbH	Directeur Général	-
Hummingbird Diagnostics GmbH	Fondateur	-
░░░ ░░░░ ░░░░ ░░░░░░░░	░░░░░░░░░░ ░ ░░░░░░░	-

Anciens postes connus de Karoly Nikolich

Sociétés	Poste	Fin
░░░░░ ░░░░░░ ░░░░	░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░░░	░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░	░░░░░░░░░░ ░ ░░░░░░░	░░░░░░░░░░

Formation de Karoly Nikolich

Tulane University (Louisiana)	Doctorate Degree
Eotvos Lorand University	Undergraduate Degree